---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295543542.md"
description: "Xtant Medical Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its fY26 sales guidance."
datetime: "2026-08-11T13:11:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295543542.md)
  - [en](https://longbridge.com/en/news/295543542.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295543542.md)
generator: "portal-rs"
---

# 

Xtant Medical Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its fY26 sales guidance.

### Related Stocks

- [XTNT.US](https://longbridge.com/en/quote/XTNT.US.md)

## Related News & Research

- [Analyst Reiterates Buy on Xtant, Citing BioHorizons Partnership and High-Margin OsteoFactor Pro as Key Growth Drivers](https://longbridge.com/en/news/297358486.md)
- [Xtant Medical partners with BioHorizons for exclusive dental distribution of allogeneic growth factor tech in US, Canada](https://longbridge.com/en/news/297181832.md)
- [ENvue Medical announces 1-for-12 reverse stock split](https://longbridge.com/en/news/297559591.md)
- [Innocan Pharma reports Q2 results](https://longbridge.com/en/news/297557245.md)
- [REG - EDX Medical Group - Director/PDMR shareholdings in the Company](https://longbridge.com/en/news/298058813.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**